SARS-CoV-2 Omicron infections pose long-COVID risks despite reduced severity

Research scientist with gloves holding blood sample on glass in laboratory. Biology doctor analyzing plasma dna for medical discovery in pharmaceutical industry. Science equipment on desk

researchers compared the post-coronavirus disease complaints and symptoms in individuals infected with the SARS-CoV-2 Omicron variant with those in individuals with Delta variant infections to understand whether the long-term complaints after Omicron infections are similar to those in infections with other SARS-CoV-2 variants.

Samsung’s Cyber Week deals are still live

Previous article

Exploring neurodevelopment among Zika virus-exposed children without Zika syndrome

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News